Company / Operating Margin
NOVAVAX INC Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
40.3%
FY2025
5-year range
-147.1% / 40.3%
FY2021-FY2025
Trend
+210.4%
vs FY2024
Sector context
#8 of 135
Health Care
What the data says
Operating Margin changed +210% YoY in FY2025, a notable deviation from the 9-year average annual change of +5%.
Based on SEC 10-K filings.
40.3% in FY2025 with a 5-year CAGR of +127.9%. Top quartile in the Health Care sector.
Improved from -57.6% to 40.3% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +127.9pp
- 5-Year Change
- +127.9pp
- 10-Year Change
- -
Sector benchmark
Top 6% in Health CareTop 6% of 135This company 40.3% Sector average -774.4%
▼
+105.2% above sector average
Key checks
Key Insights
- NOVAVAX INC's operating margin has grown for 4 consecutive years.
- In FY2025, operating margin increased 210.4% year-over-year.
- Currently 814.7pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 40.3% | +210.4% |
| FY2024 | -36.5% | +36.6% |
| FY2023 | -57.6% | +34.3% |
| FY2022 | -87.6% | +40.4% |
| FY2021 | -147.1% | -67.9% |
| FY2020 | -87.6% | +84.1% |
| FY2019 | -550.8% | +68.6% |
| FY2018 | -1752.8% | -304.1% |
| FY2017 | -433.8% | -58.9% |
| FY2016 | -273.0% | -8.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026